Showing 478 news articles about New & experimental hepatitis C treatment

Filters Content type: Editors' picks Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental HIV treatments

HIV, Hep C Drug Development Pipeline is 'Robust,' Says Report

Editor's pick
Poz magazine news
15 July 2011
New & experimental hepatitis C treatment

New Vertex hepatitis C ads focus on disease, not treatment

Editor's pick
Boston Globe
30 June 2011
Pharmaceutical industry

Vertex Tops Merck in Early Hep C Drug Launch

Editor's pick
The Street
28 June 2011
New & experimental hepatitis C treatment

Activists Call for Earlier Access to Hep C Treatments

Editor's pick
AIDSMeds
17 June 2011
New & experimental hepatitis C treatment

Copy of Activists Call for Earlier Access to Hep C Treatments

Editor's pick
Kaiser Daily Global Health Policy Report
17 June 2011
New & experimental hepatitis C treatment

Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment

Editor's pick
The Body
3 June 2011
New & experimental hepatitis C treatment

High Demand for New HCV Drugs Could Cause Ethical Problems

Editor's pick
Medscape
31 May 2011
New & experimental hepatitis C treatment

NICE to appraise hep C drugs Victrelis and telaprevir

Editor's pick
InPharm
26 May 2011
New & experimental hepatitis C treatment

Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C

Editor's pick
Achillion
26 May 2011
New & experimental hepatitis C treatment

European approval for new hepatitis C drug boceprevir (Victrelis)

Editor's pick
European Medicines Agency
20 May 2011
New & experimental hepatitis C treatment

The Fair Pricing Coalition Expresses Dismay at the Price of Merck's Newly Approved Hepatitis C Drug

Editor's pick
Thebody.com
18 May 2011
New & experimental hepatitis C treatment

Merck, Roche to Work Together on Hepatitis C Treatments

Editor's pick
San Francisco Chronicle
18 May 2011
New & experimental hepatitis C treatment

Getting Ready; Telaprevir or Boceprevir ?

Editor's pick
HCV New Drugs Research
18 May 2011
New & experimental hepatitis C treatment

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Editor's pick
New York Times
16 May 2011
New & experimental hepatitis C treatment

Vertex hepatitis C drug gets glowing endorsement

Editor's pick
Reuters
29 April 2011
New & experimental hepatitis C treatment

US FDA panel backs Merck hepatitis drug

Editor's pick
Reuters
28 April 2011
New & experimental hepatitis C treatment

Some Biotechs May Benefit From Hepatitis C Treatment Market Shift

Editor's pick
Seeking Alpha
27 April 2011
New & experimental hepatitis C treatment

Merck- Boceprevir, Vertex-Telaprevir Prep for Hep C Drug Panels

Editor's pick
The Street
21 April 2011
New & experimental hepatitis C treatment

European Gastroenterologists Will Prescribe Telaprevir and Boceprevir to Nonresponder and Treatment-Naive Patients Following Launch, Leading to Higher Treatment Costs Than Interviewed Payers Expect

Editor's pick
Business Wire
19 April 2011
New & experimental hepatitis C treatment

Pegylated Interferon Lambda Boosts Response with Few Side Effects

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Telaprevir Improves HCV Cure Rates Regardless of IL28B Status

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

First Sustained Response Data for Polymerase Inhibitor Mericitabine

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Polymerase Inhibitor PSI-7977 Works with Interferon or Companion Drug

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Avalanche of hepatitis C products on the way

Editor's pick
Pharma Times
4 April 2011